Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10213395 | International Journal of Cardiology | 2018 | 10 Pages |
Abstract
The ERK pathway acts to promote a compensated hypertrophic response, with enhanced contractile function and reduced fibrosis. The activation of this pathway may be a therapeutic strategy to preserve contractile function when the pressure overload cannot be easily alleviated. The inhibition of this pathway, which is increasingly being used for cancer therapy on the other hand, should be used with caution in the presence of pressure-overload.
Keywords
(qRT-PCR)(WT)(MAPK)(MRI)(ERK)Neonatal rat ventricular myocytesContractile functionMagnetic resonance imagingquantitative real time PCRphospholambanwildtypeCardiac hypertrophyMitogen-activated protein kinases (MAPKs)mitogen-activated protein kinasefractional shorteningextracellular signal-regulated kinaseExtracellular signal-regulated kinase (ERK)
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael Mutlak, Michal Schlesinger-Laufer, Tali Haas, Rona Shofti, Nimer Ballan, Yair E. Lewis, Mor Zuler, Yaniv Zohar, Lilac H. Caspi, Izhak Kehat,